We and others have demonstrated that CD163 is expressed and contributes to hematoma clearance following ICH (Cao et al., 2016; Liu et al., 2017; Leclerc et al., 2018), but the functions of CD163 have not been investigated after SAH. The gene discussed is CD163; the disease is hematoma.